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Abstract
Infections are often caused by pathobionts, endogenous bacteria that belong to the microbiota. Trauma and 
surgical intervention can allow bacteria to overcome host defences, ultimately leading to sepsis if left untreated. 
One of the main defence strategies of the immune system is the production of highly specific antibodies. In 
the present proof-of-concept study, plasma antibodies against 9 major pathogens were measured in sepsis 
patients, as an example of severe systemic infections. The binding of plasma antibodies to bacterial extracellular 
proteins was quantified using a semi-automated immunoblot assay. Comparison of the pathogen-specific 
antibody levels before and after infection showed an increase in plasma IgG in 20 out of 37 tested patients. 
This host-directed approach extended the results of pathogen-oriented microbiological and PCR diagnostics: 
a specific antibody response to additional bacteria was frequently observed, indicating unrecognised poly-
microbial invasion. This might explain some cases of failed, seemingly targeted antibiotic treatment.
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Introduction
Bacteria, commensals as well as pathogens, are 
constantly surrounding the human body, frequently 
as members of the microbiota. The innate and adaptive 
immune systems are responsible for preventing these 
bacteria from penetrating the protective barrier 
of skin and mucous membranes, e.g. through the 
production of specific (neutralising) antibodies 
(Byrd et al., 2018). Favoured by trauma and invasive 
surgical procedures, these endogenous opportunistic 
pathogens, also referred to as pathobionts, can 
occasionally cause severe infections, ranging from 
bone and soft tissue infections to implant-associated 
infections, up to sepsis (Benito et al., 2019). Sepsis, 
defined as a ‘life-threatening organ dysfunction 
caused by a dysregulated host response to infection’ 
(Singer et al., 2016), is a leading cause of death 
(Fleischmann et al., 2015; La Suarez De Rica et 
al., 2016). Sepsis caused by Staphylococcus aureus 
(S. aureus) induces a strain-specific IgG response. 
An increase in anti-S. aureus antibodies in patient 
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sera during an infection is observed in most patients, 
often in the early stages of the disease (Kolata et 
al., 2011). This suggests that studying the adaptive 
immune system’s reaction to bacterial invasion could 
shed light on the infection process, complementing 
pathogen-directed techniques such as microbiological 
culture and PCR methods.
 Positive microbial culture provides clinicians with 
information about the identity as well as antibiotic 
susceptibility of the causative bacterial species and, 
hence, guides a subsequent antibiotic treatment that 
is lifesaving (Dellinger et al., 2013; Kim and Park, 
2019). However, up to 70 % of all clinically diagnosed 
sepsis cases are culture-negative (Cohen et al., 2015), 
showing that standard microbiological culture lacks 
sensitivity. Moreover, standard microbiological 
culture is vulnerable to antibiotic treatment and 
sampling error (false positive or false negative), 
especially in the setting of poly-microbial infections. 
On the other hand, sequence-based pathogen 
detection by PCR allows for faster and more sensitive 
pathogen diagnostics (Trung et al., 2019) despite being 
often unable to determine whether the pathogen is 
actually responsible for the infection, leading to false 
positives (poor specificity) (Yamamoto, 2002).
 Pathogens that induce an adaptive immune 
response are probably relevant in the infection 
process and may be identified by measuring 
pathogen-specific IgGs in the blood. Such a host-
directed approach would be robust against antibiotic 
therapy. However, the interpretation of the antibody 
levels is complicated by the fact that many sepsis-
causing agents are members of the human microbiota. 
Therefore, the individual history of exposure to these 
pathobionts results in highly variable basal pathogen-
specific plasma antibody levels, precluding the 
definition of a “diagnostic threshold” (Hornef, 2015). 
Studies have previously shown that IgG titers against 
certain S. aureus proteins have a diagnostic value in 
different clinical settings, including osteomyelitis, 
diabetic foot infections, epidermolysis bullosa and 
prosthetic joint infections (PJI) (Marmor et al., 2016; 
Nishitani et al., 2015; Oh et al., 2018; van der Kooi-
Pol et al., 2013). Moreover, high basal anti-S. aureus 
antibody titers show protection against severe 
S. aureus infections/complications (Fritz et al., 2013; 
Michalik et al., 2020; Stentzel et al., 2015). However, 
little is known about the diagnostic potential of the 
antibody response against other frequent nosocomial 
pathogens.
 The measurement of increases in specific antibody 
levels during infection, as they are consistently 
observed in patients with S. aureus bacteraemia 
(Kolata et al., 2011), could also be of value in infections 
caused by other bacterial pathogens. The present 
proof-of-concept study demonstrated that sepsis 
patients developed an IgG response, which was 
specific for the invasive pathogen(s). This approach 
might complement pathogen-directed diagnosis, 
especially of secondary and poly-microbial infections.
Materials and Methods
Study design and patient material
Within a prospective clinical trial, 52 sepsis patients, 
fulfilling the 2001 consensus definition of severe 
sepsis or septic shock, were recruited at the University 
Medicine Greifswald between 2011 and 2012 (Levy et 
al., 2003). The study was approved by the institutional 
ethics committee of the University Medicine 
Greifswald (VYOO Amendment, BB138/10a). All 
patients provided written informed consent for study 
participation. Around 71 % of those sepsis patients 
(n = 37; 24 male and 13 female; age range: 28-85 years; 
median: 72 years) had a standard microbiological 
diagnosis based on blood cultures (n = 17) or 
respective sites of infection (n = 20) and were, thus, 
included in the study (for further information on the 
patient cohort consult Table 1). Results of a multiplex 
PCR test (VYOO) for the detection of pathogens in 
blood taken at sepsis diagnosis were available for 16 
of the 37 patients investigated in the study (Sachse 
et al., 2009). Among those 16 patients, 81 % (13/16) 
showed concordance with the microbiological 
findings. Moreover, poly-microbial infections 
were detected in 35 % and 24 % of the patients, by 
microbiology and PCR, respectively. 23 of the 37 
patients (62.2 %) presented with serum lactate levels 
> 2 mmol/L, fulfilling the sepsis-3 definition criterion 
for septic shock (Singer et al., 2016). For each patient, 
two plasma samples were analysed, with a median 
time span (∆T) of 16 d. For the earlier time point, 
blood was obtained either at the time of clinical 
diagnosis of sepsis (n = 37) or, whenever possible, at 
a time point before sepsis diagnosis (n = 35). This was 
possible because diagnostic samples are routinely 
stored for 6 d at the Institute of Clinical Chemistry 
and Laboratory Medicine, University Medicine 
Greifswald, Greifswald, Germany. These reserved 
diagnostic samples were made available for the 
present study and used to determine basal plasma 
antibody levels. The second patient sample was taken 
at the latest possible time point during infection. 
Two plasma samples from each of 8 healthy control 
subjects [5 male (62.5 %) and 3 female (37.5 %)], with 
a median ∆T of 20 d, were likewise analysed.
Bacterial cultivation and protein extraction
The bacterial strains isolated from positive blood 
cultures or other samples taken from sites of 
infection were stored as glycerol stocks at − 80 °C. 
For the antigen preparation, overnight cultures 
of the respective bacterial strains in tryptic soy 
broth (TBS, Oxoid Ltd, Cheshire, UK) were used to 
inoculate the main culture to an optical density (OD) 
at 595 nm of 0.05. The cultures were grown at 37 °C 
and 100 shakes per min (spm) for a total of 8 h. The 
culture supernatants were harvested and the secreted 
proteins extracted as previously described (Holtfreter 
et al., 2009). Briefly, the culture supernatant was 
filtered through a 0.2 µm membran (Merck). 
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Table 1. Baseline characteristics of the sepsis patient cohort included in the study (n = 37). 1 m, male; f, 
female. 2 B, primary bacteraemia; B/ST, bone and soft tissue infection; C, catheter-associated infection; IA, 
intraabdominal infection; P, pneumonia; U, urinary tract infection. 3 Septic shock was defined according to 
the Sepsis-3 definition by serum lactate levels > 2 mmol/L (Singer et al., 2016). 4 90-d survival. 5 A, abscess; 
C, catheter; DF, drain fluid; N, nose; P, perineum; T, tracheal secretion; W, wound. * E. faecium; E. faecalis. 
† for two patients no serum lactate levels were available. CoNS: coagulase-negative staphylococci; nd: not 
determined.
Patient characteristics Microbiological findings PCR results
ID Age Sex1
Infection 
focus2 Diagnosis3 Survival4 Blood culture Other material5 VYOO®





2 55 m IA sepsis no  E. faeciumW CoNS; E. faecium
3 76 m nd septic shock no S. aureus S. aureusT S. aureus
7 84 f IA septic shock no  E. faeciumW E. faecium
8 65 m B/ST septic shock no  S. epidermidis
W; CoNST; 
Candida speciesT S. aureus
10 81 f P septic shock no E. coli C. albicansN,P E. coli
11 72 m IA sepsis yes  S. aureusN,P  
12 50 m IA septic shock yes  E. faecalisW; C. albicansW  
13 57 f nd septic shock yes S. hominis   
14 52 f IA sepsis nd  E. coliP,DF  
15 40 f P septic shock yes S. pneumoniae;S. hominis   
16 28 m IA sepsis nd S. haemolyticus;S. epidermidis S. aureus
W  
17 78 f IA septic shock yes  E. faeciumA  
18 72 f P sepsis nd C. glabrata;S. epidermidis A. hydrophila/caviae
W  
21 60 m IA septic shock no  E. coliW E. coli; CoNS
22 56 m IA sepsis nd S. haemolyticus;E. faecalis
S. haemolyticusC;
E. faecalisC  
24 78 m IA septic shock nd  K. pneumoniae
W;
E. coliW; E. faecalisW  
25 85 f P septic shock no  EnterococciW,*  
26 77 m B/ST sepsis yes S. schleiferi S. aureusN S. aureus
27 73 m IA septic shock yes E. faecalis  E. coli; CoNS; E. faecium
28 77 m B septic shock yes E. faecalis;S. epidermidis   
29 81 m IA septic shock nd  E. coliT E. coli; CoNS
31 68 m P sepsis yes  Streptococci
T; CoNST; 
E. coliT  
32 51 m IA septic shock nd K. pneumoniae   
34 78 f B/ST septic shock no  S. aureusW  
35 75 m nd sepsis yes  K. pneumoniaeC  
36 44 m nd sepsis† nd S. marcescens   
41 49 m IA septic shock yes  E. faeciumW,T,DF B. fragilis; E. faecium;P. mirabilis
43 76 f P sepsis nd  K. oxytocaT,C S. aureus
45 46 f IA septic shock yes  P. mirabilis
W; 
EnterococciW
E. coli; E. faecium;
K. oxytoca
46 68 m nd septic shock no P. aeruginosa P. aeruginosaT B. fragilis; P. aeruginosa
47 54 m U septic shock yes  EnterococciT,C,*  
48 75 m B/ST sepsis yes S. aureus S. aureusW S. aureus




P. mirabilis; C. glabrata
51 81 m IA sepsis yes S. epidermidis




53 80 m IA septic shock yes  P. aeruginosaC  
54 70 f IA septic shock yes S. haemolyticus; E. coli   
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The secreted proteins were precipitated using 
trichloroacetic acid (TCA, Roth; final concentration 
10 %), washed with 70 % ethanol and resolved in 
rehydration buffer containing 8 M urea (Merck), 2 M 
thiourea (Merck) and 2 % 3-((3-cholamidopropyl) 
dimethylammonio)-1-propanesulphonate (CHAPS; 
Merck). Protein concentrations were measured using 
the Bradford Protein Assay (Bio-Rad) (Bradford, 
1976). The purified protein samples were stored at 
− 80 °C.
 For S. aureus, the protein-A-deficient mutant 
of strain USA300 (S. aureus USA300∆spa; Stentzel 
et al., 2015) was used to prevent non-specific 
antibody binding. Moreover, staphylococci were 
cultured under iron limitation, namely in TSB 
supplemented with 2,2’-bipyridyl (Sigma-Aldrich; 
final concentration 600 μM), to enhance the secretion 
of immunogenic proteins (Stentzel et al., 2014).
Semi-automated immunoblot assay
Antibody binding to extracellular proteins of 
common sepsis pathogens as well as tetanus toxoid 
(TT, Statens Serum Institute, Copenhagen, Denmark) 
was quantified using semi-automated quantitative 
immunoblotting (Peggy Sue™ Simple Western 
Assay; ProteinSimple®, Santa Clara, CA, USA), 
which uses capillary electrophoresis for antigen 
separation followed by exposure to the antibody 
samples and quantification of antibody binding 
by chemiluminescence. Two plasma samples per 
study subject were analysed, one obtained at the 
earliest and one at the latest available time point. 
Antigen-specific plasma antibodies were measured 
according to the Peggy Sue™ Simple Western Assay 
manual (Kit: 12-230 kDa Peggy Sue™ or Sally Sue™ 
Separation Module SM-S001 and DM-003) using 
1 mg/mL and 0.2 mg/mL of extracellular proteins 
and TT, respectively. In brief, bacterial proteins 
were mixed with 5× mastermix containing sample 
buffer, DTT and a fluorescent standard. Protein 
samples and biotinylated molecular weight (MW) 
standards from ProteinSimple® were heated for 
5 min at 95 °C. Human plasma samples served as 
the source of primary antibodies and their dilution 
was optimised for each bacterial species (1 : 1,000 to 
1 : 10,000) (Table 2). The polyclonal detection antibody 
[goat anti-human IgG (H+L) horse-radishperoxidase 
(POD)-conjugated; 109-035-088, Dianova, Hamburg, 
Germany] was used at a final concentration of 0.8 ng/
mL. The different reagents, including protein samples, 
blocking reagent, diluted plasma samples, detection 
antibody, chemiluminescent substrate, separation 
and stacking matrices were loaded to designated 
wells in a 384-well plate. The plate was loaded into 
the instrument and separation as well as detection 
steps were performed automatically, analogous 
to standard immunoblotting procedures. The 
chemiluminescence signals generated upon reaction 
Table 2. Settings for immunoblot assays. Group 1 bacteria are the most common sepsis pathogens. Group 
2 bacteria were used for a personalised approach in selected cases.
Sample Dilution
Exoproteomes of the following bacterial 







Enterococcus faecium 1 : 2,000
Escherichia coli 1 : 2,000
Serratia marcescens 1 : 2,000
Pseudomonas aeruginosa 1 : 2,000
Klebsiella pneumoniae 1 : 2,000 1 : 1,000
Streptococcus pneumoniae 1 : 2,000
Staphylococcus aureus 1 : 10,000
Staphylococcus epidermidis 1 : 4,000
Staphylococcus haemolyticus 1 : 4,000
Group 2
Staphylococcus hominis 1 : 1,000
Enterococcus faecalis 1 : 1,000 1 : 2,000
Proteus mirabilis 1 : 2,000 1 : 1,000
Klebsiella oxytoca 1 : 1,000
Tetanus toxoid (final concentration: 0.2 mg/mL) 1 : 4,000
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with a luminol/peroxide substrate solution were 
displayed as electropherograms and automatically 
analysed using Compass for SW software Version 
3.1.7 (ProteinSimple®). The areas under the curve of 
manually set peaks (peak fit width, 2; baseline, 0; area 
calculation, Gaussian fit) were summed to obtain the 
total signal. Data were analysed and visualised using 
GraphPadPrism Version 6 (GraphPad Software). The 
increase in pathogen-specific IgG was determined by 
comparing plasma antibody binding during sepsis 
with that prior to infection. To exclude non-specific 
B cell activation in the study cohort, plasma antibody 
binding to the recall antigen TT was also measured 
at both time points.
Statistical analysis
The statistical analysis was performed using 
GraphPad Prism Version 6. To compare changes in 
plasma IgG binding in healthy subjects and sepsis 
patients, the data were analysed using the unpaired 
t-test. p ≤ 0.05 was considered statistically significant.
Results
Basal levels of pathogen-specific plasma IgG 
binding in healthy subjects showed substantial 
inter-individual and inter-species variations (Fig. 
1). However, binding of plasma IgG to TT or to 
the extracellular proteins of the 9 most common 
sepsis-causing bacteria (listed in Table 2, group 1) 
did not change significantly over time (mean = 0.9-
fold; ∆T = 20 d; Fig. 2). Therefore, the threshold for 
a significant rise in antibody binding was set, based 
on results from healthy subjects, to a 1.6-fold increase 
[mean + 3× standard deviation (SD)].
 When tested for increases in IgG binding to the 
microbiologically diagnosed infectious agents, the 
microbiological diagnosis was corroborated in 20 
out of 37 sepsis patients (54 %) (Fig. 2, ∆T = 16 d). 
In contrast, the anti-TT antibody levels remained 
stable in most of the patients as already observed 
for the healthy control group. However, due to one 
outlier (patient 28), the mean concentration of plasma 
antibodies against the recall antigen TT increased 
slightly in the sepsis patient group (Fig. 2).
 To assess the specificity of the anti-bacterial 
responses, patients showing an increase in pathogen-
specific antibody binding were further analysed for 
their antibody responses to the 9 most frequently 
diagnosed bacterial species. 3 groups of patients 
could be distinguished (Fig. 3, Table 3).
• In 4 patients, IgG binding to a single pathogen, 
also identified in the blood culture, increased 
significantly (9- to 37-fold) and in two cases, 
patient 10 and 46, the result was additionally 
confirmed by PCR (Fig. 3a, Table 3). Together 
with the lack of significant changes in the anti-TT 
titers, this confirmed that the antibody responses 
were caused by the invasive bacteria.
• In 15 patients, most of whom suffered intra-
abdominal infections, antibody responses to 
additional pathogens were observed. 5 of those 
patients exhibited only minor increases in IgG 
levels (1.6- to 5-fold). In 9 of the 15 patients, the 
strongest increase in plasma antibodies was 
directed against the microbiologically diagnosed 
pathogen (Fig. 3b, Table 3). In the remaining 6 
cases bacteria other than the microbiologically 
diagnosed ones elicited a stronger IgG response 
(Fig. 3c, Table 3). In patient 41, for example, 
E. faecium was identified by both microbiology 
Fig. 1. Basal pathogen-specific 
plasma IgG levels in healthy 
subjects. Plasma IgG binding 
to extracellular proteins of 
frequent sepsis pathogens was 
quantified using semi-automated 
quantitative immunoblotting. TT 
served as a control antigen (grey 
squares). Plasma samples were 
diluted between 1 : 2,000 and 
1 : 10,000, as indicated, to ensure 
measurement within the linear 
range of the assay (Table 2). The 
area under the curve of manually 
set peaks was calculated using 
Compass SW Version 3.1.7. All 
signals were added to obtain the 
total signal of antibody binding 
(AU, arbitrary units). Squares 
show the mean values of two 
replicates; means are indicated. 
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Fig. 2. Antibody kinetics in healthy subjects and sepsis patients. Plasma antibody binding to the recall 
antigen TT, as well as to extracellular proteins of frequent sepsis pathogens, was quantified using semi-
automated quantitative immunoblotting. In patients, plasma antibody binding during infection was 
compared with that prior to the clinical diagnosis of sepsis using routinely reserved diagnostic samples. 
In healthy subjects, a comparable time period was investigated. In healthy subjects, the plasma antibodies 
specific for all tested antigens remained stable over time (∆T = 20 d). The same was observed for the TT-
specific antibody levels in sepsis patients (∆T = 16 d). In contrast, many sepsis patients showed a significant 
increase in plasma antibody binding directed against the diagnosed pathogen. Red lines mark the threshold 
of increase (mean + 3× SD; values of healthy subjects). Single squares (healthy subjects) and dots (sepsis 
patients) show the means of two replicate values; means are indicated. Healthy subjects and sepsis patients 
were compared using the unpaired t-test. *** p < 0.001.
and PCR, whereas the increase in IgG binding 
against S. marcescens exceeded the increase 
against E. faecium by more than 10-fold.
• In 1 patient, a pronounced increase in anti-TT 
antibodies exceeded the pathogen-specific 
responses; however, the minor increases against 
enterococci and S. epidermidis were still consistent 
with the microbiological findings (patient 28, 
Table 3).
 In 21 of the 37 patients examined, no pathogen 
could be identified by PCR. Interestingly, 17 of these 
patients showed only minor increases in IgG levels 
(≤ 5-fold). Of the 16 patients with positive PCR results, 
the pathogen diagnosis result was concordant with 
the observed antibody increase in 9 cases (56 %). 
Similarly, the serological approach was often able 
to identify other or additional pathogens when 
compared to PCR. In 4 PCR-negative patients (patients 
14, 15, 36 and 51, Table 1) a possible causative agent 
could be diagnosed with the serological approach 
used.
Discussion
Serological assays are widely used in disease 
diagnostics, but typically employ (single/multiple) 
well-defined recombinant proteins to detect 
pathogen-specific antibodies. For instance, a study 
of patients suffering PJI used a selection of 16 
recombinant proteins from 5 different bacterial 
species to determine serum IgG levels. Indeed, 
staphylococcal infections were identified with 
a sensitivity/specificity of 72.3 % and 80.7 %, 
respectively (Marmor et al., 2016). In another study 
by Nishitani et al. (2015), where 14 protein candidates 
were tested in a patient cohort with S. aureus culture-
confirmed musculoskeletal infections, the S. aureus 
antigens IsdB and Hla showed the highest diagnostic 
value. Nevertheless, the authors recommended the 
use of a larger set of antigens, allowing for a higher 
sensitivity as compared to a single antigen.
 To establish a reliable diagnostic assay, it would 
be necessary to identify immunogenic proteins 
that are conserved within a species of interest, to 
ensure optimal sensitivity and specificity. However, 
nosocomial infections, including sepsis, are usually 
caused by a multitude of different bacterial species. 
Furthermore, the immune proteome of some of 
those pathogens is often still enigmatic. This has 
prompted the exploration in the present study of a 
novel approach, where complex protein extracts from 
common sepsis pathogens were used to determine 
IgG binding in sepsis patients as well as healthy 
subjects, using a semi-automated quantitative 
immunoblot assay.
 The humoral response to antigenic or inflammatory 
challenges, such as infection, vaccination or trauma, 
has been proposed to comprise the polyclonal 
activation of memory B cells of unrelated specificity 
(Bernasconi et al., 2002). Remarkably, in the absence of 
N Normann et al.                                                                                            Antibody profiles in critically ill patients
177 www.ecmjournal.org
exposure to the recall antigen TT, a moderate increase 
in anti-TT IgG was found in patients following 
cardiothoracic surgery (Pötschke et al., 2012). Hence, 
to account for a possible non-specific B cell activation 
in the study patient cohort, the anti-TT IgG response 
was also monitored. At first, IgG binding to 9 common 
sepsis pathogens (Table 2, group 1) was measured in 
the healthy control group (Fig. 1) and basal antibody 
Fig. 3. Pathogen-specific antibody responses in sepsis patients. Plasma antibody binding to extracellular 
proteins of frequent sepsis pathogens was quantified using semi-automated quantitative immunoblotting. 
TT served as a control antigen. Plasma antibody binding during infection was compared with that prior to 
clinical diagnosis of sepsis. In patients showing an increase in plasma antibody binding directed against 
the diagnosed pathogen, plasma antibody binding to all 9 sepsis pathogens was determined. 3 typical cases 
are shown, where serology was consistent with the microbiological culture and PCR. (a) IgG binding was 
selectively increased to a single pathogen; (b) additional pathogens were identified by serology; (c) the 
strongest IgG response was caused by bacteria other than the microbiologically diagnosed ones. Red lines 
mark the threshold of increase (mean + 3× SD; values of healthy subjects, Fig. 2). Bars represent individual 
values. Colours indicate whether pathogens were diagnosed by microbiological culture [green, blood culture 
(BC); orange, other microbiological culture]; colour in combination with hatching indicates concordance of 
microbiological and PCR results; the grey area shows the response to the control antigen TT. 
Table 3. Heatmap to visualise the increases in pathogen-specific and TT-specific antibody levels in the 
sera of all 20 sepsis patients who showed an increase. For each patient, the two time points of plasma 
sampling, at which the pathogen-specific IgG binding was determined, are shown. Furthermore, the 
increase in IgG response, the microbiological diagnosis and the focus of infection are listed. The patients are 
grouped according to the 3 typical cases mentioned in the text and shown in Fig. 3a-c. ND, not determined. 
1ECOL (E. coli); ENTFA (E. faecalis); ENTFC (E. faecium); KLEO (K. oxytoca); KLEP (K. pneumoniae); PROM 
(P. mirabilis); PSEA (P. aeruginosa); SERM (S. marcescens); STAA (S. aureus); STAE (S. epidermidis); STAHA 
(S. haemolyticus); STAHO (S. hominis); STRP (S. pneumoniae). 2B, primary bacteraemia; B/ST, bone and soft 
tissue infection; IA, intraabdominal infection; P, pneumonia.
178 www.ecmjournal.org
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titers against all bacterial species were observed. 
The antibody titers showed a broad inter-individual 
variation but were generally higher for S. aureus. 
This could be explained by the ubiquitous nature 
of S. aureus, where humans are regularly exposed 
to this microorganism, often within the first hours 
of life (Maayan-Metzger et al., 2017; Verkaik et al., 
2010). Therefore, S. aureus-specific IgGs are regularly 
observed in healthy adults, independent of their 
carrier status, albeit at highly varying concentrations 
(Wertheim et al., 2005). This was also reflected in the 
study healthy group, which comprised 6 S. aureus 
non-carriers, a persistent carrier and an intermittent 
carrier.
 Sepsis is often caused by commensals or 
pathobionts, which belong to the physiological 
microbiota but can cause severe infection in 
immunocompromised hosts. Healthy humans 
gradually acquire systemic immune memory of 
those bacteria, which is reflected by the presence of 
specific IgG antibodies (Bröker et al., 2014). These 
are probably induced by repeated minor bacterial 
invasions (Macpherson et al., 2005), which explains 
the presence of specific antibodies in healthy adults, 
as well as the basal antibody levels among the patients 
included in the study. For instance, plasma antibodies 
could also be detected against the skin commensal 
S. epidermidis. The observation that S. epidermidis 
colonises humans more often than S. aureus but is less 
virulent and invasive (Massey et al., 2006) is consistent 
with the present study data (Fig. 1).
 The anti-bacterial antibodies in healthy subjects 
were highly variable in terms of binding patterns and 
titers but changed little over time (Fig. 2 and Verkaik 
et al., 2009). On the other hand, the present study 
showed that in most sepsis patients, the specific IgG 
levels increased considerably during the course of the 
infection. Similar observations have been reported in 
patients with S. aureus bloodstream infection, where 
these increases in IgG titers were clearly driven by 
the invasive pathogen (Kolata et al., 2011). Many 
sepsis patients experienced a slight increase in anti-
TT IgG binding (Fig. 2). However, this was – except 
for one case (patient 28) – much lower than that of 
the anti-bacterial response, confirming the generation 
of a species-specific IgG response. When sepsis 
patients were tested for changes in IgG binding to 
9 common sepsis pathogens, the response patterns 
were highly individual and discriminated between 
different infectious agents. In 4 patients, the increase 
in IgG was selective for 1 single microbiologically-
diagnosed pathogen. Interestingly, a case report has 
previously provided evidence that the anti-bacterial 
IgG response is even strain-specific. In an S. aureus 
carrier, the increase in antibody binding is specific 
for the extracellular proteins of the invasive clinical 
S. aureus isolate, rather than the colonising strain 
(Kolata et al., 2011). Although cross-reactions between 
related bacterial species are expected, especially when 
working with complex bacterial protein extracts, the 
comparison of increases in antibody titers against the 
three tested staphylococcal species often showed a 
dominant reaction against only one of them (Table 
3). The same holds true for Gram-negative bacteria, 
where no obvious cross-reactivity among the 
different species was observed but rather, a species-
specific immune response.
 In the present proof-of-concept study, 20 out of 
37 sepsis patients with a microbiological diagnosis 
developed a humoral immune response against the 
pathogen diagnosed by either microbial culture or 
PCR. Remarkably, in 15 of these patients there was 
an antibody response to additional undiagnosed 
bacteria. Consistent with the serological findings, 
most of those patients suffered from an intra-
abdominal infection due to gut perforation or surgical 
suture failure. Hence, the immunological approach 
was often more sensitive than conventional microbial 
culture-based diagnostics, indicating a poly-microbial 
infection. In patient 41, for instance, E. faecium was 
microbiologically identified; however, the increase in 
IgG binding to S. marcescens exceeded that observed 
for the diagnosed pathogen by 10-fold. This could 
have two explanations: either S. marcescens was the 
actual cause of infection or the basal anti-S. marcescens 
antibody levels were very low when compared to 
those against E. faecium. Since the baseline situation 
significantly influenced the magnitude of the 
calculated ratio, this could lead to an overestimation 
of the observed antibody increase for S. marcescens. It 
is worth mentioning that S. marcescens was diagnosed 
in the blood culture of a single patient (patient 36), but 
not by PCR. An immune reaction against pathogens 
undetected by microbiological diagnosis could 
explain cases of failed antimicrobial therapy despite 
a seemingly targeted selection of antibiotics.
 The study further demonstrated that, while 
the pre-existing anti-bacterial antibody titers were 
highly variable (Fig. 1), increases in anti-bacterial 
IgG were indicative of an infection and specific to the 
infectious agent. Similar observations were made in 
children with musculoskeletal S. aureus infections. 
Although this young cohort presented with low basal 
anti-S. aureus antibody levels, the diagnostic power of 
antibody titer changes was higher than that of single 
measurements at diagnosis (Wood et al., 2018).
 The present proof-of-concept study has some 
limitations. First, the healthy subjects were not strictly 
sex- and age-matched to the sepsis patients. Second, 
17 out of 37 patients showed no increase in specific 
plasma IgG against the microbiologically diagnosed 
pathogen, which might be for various reasons:
• the microbiologically diagnosed pathogen did not 
cause the infection, but was merely a contaminant 
and, hence, did not elicit an immune response;
• at the first time point of antibody determination, 
the disease process was already too advanced to 
observe an appreciable increase;
• serum conversion occurred after the second blood 
sample was collected;
• the patients were unable to generate an efficient 
immune response due to immunosuppression;
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• the immediate initiation of an appropriate 
antibody therapy reduced the bacterial load so 
rapidly that no immune response was triggered.
Nevertheless, the study clearly showed that a focus 
on the immunological host response to sepsis-
causing agents can add valuable information to 
microbiological and molecular diagnostics, which 
target the pathogen. It offers several advantages over 
those established techniques that might warrant the 
implementation of this approach alongside routine 
diagnostics. For instance, it is often challenging to 
cultivate pathogens from biofilms of PJIs, where 
culture-based methods would require invasive 
surgery to access the pathogens. In such cases, 
a serological non-invasive approach would be 
of great benefit. Moreover, its readout is robust 
against antibiotic treatment and it can discriminate 
immunologically relevant infection from sample 
contamination.
 In the future, efforts will be made to improve and 
optimise both the sensitivity and the selectivity of this 
approach, by supplementing the complex antigen 
mixtures with panels of recombinant species-specific 
antigens, in order to clearly distinguish between 
immune reactions against closely related species, 
such as S. aureus and S. epidermidis.
Conclusion
Increases in antibacterial antibodies provided 
valuable insights into the infection process. While in 
an acute infection the antibody response develops too 
late for early pathogen identification and guidance 
of the initial antibiotic treatment, it can help validate 
the diagnosis, especially in patients with chronic 
infections that often occur in association with 
indwelling medical devices/materials. The extent 
to which higher antibody titers against pathobionts 
provide clinical protection and could inform the 
development of immunisation strategies against 
pathobionts remains to be investigated.
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Discussion with Reviewer
Gowrishankar Muthukrishnan: What is the rationale 
for choosing an immunoblot assay as opposed to 
other approaches to assess IgG responses?
Authors: The Peggy Sue™ Simple Western Assay 
is a semi-automated quantitative immunoblotting 
that allows for the simultaneous analysis of up to 88 
samples in a short time. Moreover, only small sample 
volumes are required, which is especially important 
when working with patient material. The results can 
be displayed as electropherograms, indicating the 
antibody binding profiles with information about 
the MW of the sample, or can be automatically 
transformed into area under the curve (AUC) for 
quantification. Therefore, the Peggy Sue™ Simple 
Western Assay is superior to an enzyme-linked 
immunosorbent assay (ELISA). Nevertheless, the 
assay has some limitations. Only one analyte can be 
measured at a time. In the future, we hope to improve 
the assay by using recombinant proteins of different 
pathogens and by using the Luminex technology 
to quantify the antibody response against several 
antigens simultaneously.
Editor’s note: The Scientific Editor responsible for 
this paper was Fintan Moriarty.
